Your browser doesn't support javascript.
loading
Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).
Lombardi, Giuseppe; Pace, Andrea; Pasqualetti, Francesco; Rizzato, Simona; Faedi, Marina; Anghileri, Elena; Nicolotto, Elisa; Bazzoli, Elena; Bellu, Luisa; Villani, Veronica; Fabi, Alessandra; Ferrazza, Patrizia; Gurrieri, Lorena; Dall'Agata, Monia; Eoli, Marica; Della Puppa, Alessandro; Pambuku, Ardi; D'Avella, Domenico; Berti, Franco; Rudà, Roberta; Zagonel, Vittorina.
Afiliação
  • Lombardi G; Department of Clinical and Experimental Oncology, Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, via Gattamelata, 64, 35128, Padua, Italy. giuseppe.lombardi@ioveneto.it.
  • Pace A; Neuro-Oncology Unit, "Regina Elena" National Cancer Institute, Rome, Italy.
  • Pasqualetti F; Department of Radiotherapy, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Rizzato S; Department of Oncology, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy.
  • Faedi M; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Anghileri E; Unit of Molecular Neuro-Oncology, Fondazione I.R.C.C.S. Istituto Neurologico C. Besta, Milan, Italy.
  • Nicolotto E; Department of Neuro-Oncology, University of Turin and City of Health and Science, University Hospital, Turin, Italy.
  • Bazzoli E; Department of Neurological and Movement Sciences, University of Verona, Verona, Italy.
  • Bellu L; IRCCS, Centro S. Giovanni di Dio - Fatebenefratelli, Brescia, Italy.
  • Villani V; Department of Clinical and Experimental Oncology, Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, via Gattamelata, 64, 35128, Padua, Italy.
  • Fabi A; Neuro-Oncology Unit, "Regina Elena" National Cancer Institute, Rome, Italy.
  • Ferrazza P; Division of Medical Oncology, "Regina Elena" National Cancer Institute, Rome, Italy.
  • Gurrieri L; Department of Radiotherapy, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
  • Dall'Agata M; Department of Oncology, Azienda Ospedaliero-Universitaria di Udine, Udine, Italy.
  • Eoli M; Biostatistics and Clinical Trials Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.
  • Della Puppa A; Unit of Molecular Neuro-Oncology, Fondazione I.R.C.C.S. Istituto Neurologico C. Besta, Milan, Italy.
  • Pambuku A; Neurosurgery Department, Azienda Ospedaliera di Padova, Padua, Italy.
  • D'Avella D; Department of Clinical and Experimental Oncology, Medical Oncology 1, Veneto Institute of Oncology IOV - IRCCS, via Gattamelata, 64, 35128, Padua, Italy.
  • Berti F; Neurosurgery Department, University of Padua, Padua, Italy.
  • Rudà R; Radiation Therapy and Nuclear Medicine Unit, Veneto Institute of Oncology IOV IRCCS, Padua, Italy.
  • Zagonel V; Department of Neuro-Oncology, University of Turin and City of Health and Science, University Hospital, Turin, Italy.
J Neurooncol ; 125(2): 359-67, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26423801

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Antineoplásicos Alquilantes / Dacarbazina / Quimiorradioterapia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Antineoplásicos Alquilantes / Dacarbazina / Quimiorradioterapia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2015 Tipo de documento: Article